Catalyst Alerts

Get notified when biotech catalysts fire — FDA dates, trial updates, insider buying, and more.

Recent Catalyst Events

■

ABSIAbsci Corporation2026-04-22

Short Squeeze Setup: ABSI — 29.5% float short, HIGH squeeze risk

■

ABCLAbCellera Biologics2026-04-22

Short Squeeze Setup: ABCL — 22.7% float short, HIGH squeeze risk

■

ABEOAbeona Therapeutics Inc.2026-04-22

Short Squeeze Setup: ABEO — 32.4% float short, HIGH squeeze risk

■

ACHCAcadia Healthcare Company, Inc.2026-04-22

Short Squeeze Setup: ACHC — 27.2% float short, HIGH squeeze risk

■

ACLXArcellx Inc2026-04-22

Short Squeeze Setup: ACLX — 23.5% float short, HIGH squeeze risk

■

ANABAnaptysBio Inc2026-04-22

Short Squeeze Setup: ANAB — 27.9% float short, HIGH squeeze risk

■

ARCTArctus Therapeutics2026-04-22

Short Squeeze Setup: ARCT — 24.5% float short, HIGH squeeze risk

■

ASMBAssembly Biosciences2026-04-22

Short Squeeze Setup: ASMB — 20.4% float short, HIGH squeeze risk

■

ATYRaTyr Pharma, Inc.2026-04-22

Short Squeeze Setup: ATYR — 20.5% float short, HIGH squeeze risk

■

AUTLAutolus Therapeutics2026-04-22

Short Squeeze Setup: AUTL — 43.0% float short, HIGH squeeze risk

■

AVBPArriVent BioPharma, Inc.2026-04-22

Short Squeeze Setup: AVBP — 28.0% float short, HIGH squeeze risk

■

AVTXAvalo Therapeutics, Inc.2026-04-22

Short Squeeze Setup: AVTX — 27.5% float short, HIGH squeeze risk

■

AVXLAnavex Life Sciences2026-04-22

Short Squeeze Setup: AVXL — 21.4% float short, HIGH squeeze risk

■

BBNXBeta Bionics, Inc.2026-04-22

Short Squeeze Setup: BBNX — 32.2% float short, HIGH squeeze risk

■

BCAXBicara Therapeutics Inc.2026-04-22

Short Squeeze Setup: BCAX — 22.8% float short, HIGH squeeze risk

■

BEAMBeam Therapeutics2026-04-22

Short Squeeze Setup: BEAM — 26.6% float short, HIGH squeeze risk

■

CABACabaletta Bio2026-04-22

Short Squeeze Setup: CABA — 21.9% float short, HIGH squeeze risk

■

CADLCandel Therapeutics, Inc.2026-04-22

Short Squeeze Setup: CADL — 23.4% float short, HIGH squeeze risk

■

CAPRCapricor Therapeutics, Inc.2026-04-22

Short Squeeze Setup: CAPR — 20.3% float short, HIGH squeeze risk

■

CCCCC4 Therapeutics, Inc.2026-04-22

Short Squeeze Setup: CCCC — 24.2% float short, HIGH squeeze risk

Not financial advice. BiotechSign alerts are for research and informational purposes only.